Literature DB >> 26885033

Cytochrome P450 2C9 (CYP2C9) polymorphisms in Chinese Li population.

Yipeng Ding1, Danlei Yang2, Long Zhou3, Ping He1, Jinjian Yao1, Pingdong Xie1, Daobo Lin1, Dingwei Sun1, Pei Sun1, Quanni Li1, Tingting Geng4, Tianbo Jin5.   

Abstract

BACKGROUND: The frequencies of Cytochrome P450 2C9 (CYP2C9) genotypes were various between populations. The aim of this study was to investigate the frequencies of the major variants of the CYP2C9 in Chinese Li minority populations.
METHODS: The promoter, exons and surrounding introns, and 3'-untranslated region of the CYP2C9 gene was detected by DNA sequencing to investigate in 100 unrelated healthy Chinese Li subjects. The protein function prediction was used the online tools: Sorting Intolerant From Tolerant (SIFT) and Phenotyping Version 2 (PolyPhen-2). The comparison of CYP2C9 allele frequencies in different populations were analyzed by Chi-square (χ(2)) test. Linkage disequilibrium (LD) analysis was performed using Haploview software.
RESULTS: We identified 17 different CYP2C9 single nucleotide polymorphisms (SNPs) in the Li population, including two missense mutations (3549 G > A and 42614 A > C) and two silent mutations (3514 T > Cand 50298A > T). The protein function prediction revealed the two missense mutations result in protein damaging. In addition, we detected the allele frequencies of CYP2C9*1, CYP2C9*3 and CYP2C9*42 were 98%, 1%, and 1%, respectively. Finally, we compared three major allelic frequency (CYP2C9*1, CYP2C9*2, and CYP2C9*3) between Li and other populations. We found that our results were similar to East Asians and Africans.

Entities:  

Keywords:  CYP2C9; CYP2C9*1; CYP2C9*3; CYP2C9*42; Chinese Li minority populations; allele frequencies

Year:  2015        PMID: 26885033      PMCID: PMC4723878     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  54 in total

1.  Allele and genotype frequencies of the polymorphic cytochrome P450 genes (CYP1A1, CYP3A4, CYP3A5, CYP2C9 and CYP2C19) in the Jordanian population.

Authors:  Al-Motassem Yousef; Nailya R Bulatova; William Newman; Nancy Hakooz; Said Ismail; Hisham Qusa; Farah Zahran; Nidaa Anwar Ababneh; Farah Hasan; Imad Zaloom; Ghada Khayat; Rawan Al-Zmili; Randa Naffa; Ola Al-Diab
Journal:  Mol Biol Rep       Date:  2012-06-22       Impact factor: 2.316

2.  Genetic polymorphisms of cytochrome P450 enzymes 2C9 and 2C19 in a healthy Mongolian population in China.

Authors:  Z F Yang; H W Cui; T Hasi; S Q Jia; M L Gong; X L Su
Journal:  Genet Mol Res       Date:  2010-09-14

3.  Combined CYP2C9, VKORC1 and CYP4F2 frequencies among racial and ethnic groups.

Authors:  Stuart A Scott; Rame Khasawneh; Inga Peter; Ruth Kornreich; Robert J Desnick
Journal:  Pharmacogenomics       Date:  2010-06       Impact factor: 2.533

4.  Interethnic differences in the relevance of CYP2C9 genotype and environmental factors for diclofenac metabolism in Hispanics from Cuba and Spain.

Authors:  A Llerena; M Alvarez; P Dorado; I González; E Peñas-LLedó; B Pérez; J Cobaleda; L R Calzadilla
Journal:  Pharmacogenomics J       Date:  2013-08-20       Impact factor: 3.550

5.  Genetic polymorphisms of drug-metabolizing phase I enzymes CYP3A4, CYP2C9, CYP2C19 and CYP2D6 in Han, Uighur, Hui and Mongolian Chinese populations.

Authors:  Jinliang Zuo; Dongya Xia; Lihui Jia; Tao Guo
Journal:  Pharmazie       Date:  2012-07       Impact factor: 1.267

6.  CYP2C9 polymorphism analysis in Han Chinese populations: building the largest allele frequency database.

Authors:  D-P Dai; R-A Xu; L-M Hu; S-H Wang; P-W Geng; J-F Yang; L-P Yang; J-C Qian; Z-S Wang; G-H Zhu; X-H Zhang; R-S Ge; G-X Hu; J-P Cai
Journal:  Pharmacogenomics J       Date:  2013-02-12       Impact factor: 3.550

7.  Genetic polymorphism of cytochrome P450 2C9 in a Caucasian and a black African population.

Authors:  M G Scordo; E Aklillu; U Yasar; M L Dahl; E Spina; M Ingelman-Sundberg
Journal:  Br J Clin Pharmacol       Date:  2001-10       Impact factor: 4.335

Review 8.  Clinical relevance of genetic polymorphisms in the human CYP2C subfamily.

Authors:  J A Goldstein
Journal:  Br J Clin Pharmacol       Date:  2001-10       Impact factor: 4.335

9.  Human non-synonymous SNPs: server and survey.

Authors:  Vasily Ramensky; Peer Bork; Shamil Sunyaev
Journal:  Nucleic Acids Res       Date:  2002-09-01       Impact factor: 16.971

10.  Frequency of cytochrome P450 2C9 allelic variants in the Chinese and French populations.

Authors:  Jue Quin Yang; Sandrine Morin; Céline Verstuyft; Li An Fan; Yong Zhang; Chun Di Xu; Véronique Barbu; C Funck-Brentano; Patrice Jaillon; Laurent Becquemont
Journal:  Fundam Clin Pharmacol       Date:  2003-06       Impact factor: 2.748

View more
  3 in total

1.  ADAM33 gene polymorphisms identified to be associated with asthma in a Chinese Li population.

Authors:  Bo Shen; Rong Lin; Cai-Chun Wang; Jing Rei; Yan Sun; Yong-Le Yang; Ying-Ying Lin
Journal:  Biomed Rep       Date:  2017-02-08

Review 2.  Genophenotypic Factors and Pharmacogenomics in Adverse Drug Reactions.

Authors:  Ramón Cacabelos; Vinogran Naidoo; Lola Corzo; Natalia Cacabelos; Juan C Carril
Journal:  Int J Mol Sci       Date:  2021-12-10       Impact factor: 5.923

3.  Physiologically based pharmacokinetic (PBPK) modeling for prediction of celecoxib pharmacokinetics according to CYP2C9 genetic polymorphism.

Authors:  Young-Hoon Kim; Pureum Kang; Chang-Keun Cho; Eui Hyun Jung; Hye-Jeong Park; Yun Jeong Lee; Jung-Woo Bae; Choon-Gon Jang; Seok-Yong Lee
Journal:  Arch Pharm Res       Date:  2021-07-25       Impact factor: 4.946

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.